Information:
Fel:
ID
23041
Beskrivning
Long-acting Injectable Risperidone in Patients With Schizophrenia After an Acute Episode; ODM derived from: https://clinicaltrials.gov/show/NCT00216671
Länk
https://clinicaltrials.gov/show/NCT00216671
Nyckelord
Versioner (1)
- 2017-06-20 2017-06-20 -
Uppladdad den
20 juni 2017
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Schizophrenia NCT00216671
Eligibility Schizophrenia NCT00216671
- StudyEvent: Eligibility
Similar models
Eligibility Schizophrenia NCT00216671
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Schizophrenia
Item
diagnosis of schizophrenia by criteria of diagnostic and statistical manual of mental diseases, fourth edition (dsm-iv)
boolean
C0036341 (UMLS CUI [1])
Acute schizophrenic episode
Item
acute episode of schizophrenia within 2 weeks of study entry
boolean
C0813173 (UMLS CUI [1])
Study Subject untreated | Antipsychotic Agents Oral | Antipsychotic Agents Injectable Active short-term | Zuclopenthixol
Item
o subjects currently not treated or treated with oral antipsychotics or short-acting injectable antipsychotics (zuclopenthixol acutard is allowed) at doses not exceeding the registered dose
boolean
C0681850 (UMLS CUI [1,1])
C0332155 (UMLS CUI [1,2])
C0040615 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0040615 (UMLS CUI [3,1])
C0086466 (UMLS CUI [3,2])
C0205177 (UMLS CUI [3,3])
C0443303 (UMLS CUI [3,4])
C0376160 (UMLS CUI [4])
C0332155 (UMLS CUI [1,2])
C0040615 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0040615 (UMLS CUI [3,1])
C0086466 (UMLS CUI [3,2])
C0205177 (UMLS CUI [3,3])
C0443303 (UMLS CUI [3,4])
C0376160 (UMLS CUI [4])
Positive and negative syndrome scale
Item
positive and negative syndrome scale (panss) score >=80
boolean
C0451383 (UMLS CUI [1])
Clinical Global Impression Questionnaire
Item
clinical global impression - severity (cgi-s) score >=5
boolean
C3639708 (UMLS CUI [1])
Axis I diagnosis | Schizophrenia
Item
dsm-iv axis i diagnosis other than schizophrenia
boolean
C0270287 (UMLS CUI [1])
C0036341 (UMLS CUI [2])
C0036341 (UMLS CUI [2])
Risperidone allergy | Risperidone Absent response to treatment
Item
known hypersensitivity or lack of response to risperidone
boolean
C0570837 (UMLS CUI [1])
C0073393 (UMLS CUI [2,1])
C0438286 (UMLS CUI [2,2])
C0073393 (UMLS CUI [2,1])
C0438286 (UMLS CUI [2,2])
Pregnancy | Breast Feeding | Gender Contraceptive methods Inadequate
Item
pregnant or nursing females, or those without adequate contraception
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0079399 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C0205412 (UMLS CUI [3,3])
C0006147 (UMLS CUI [2])
C0079399 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C0205412 (UMLS CUI [3,3])
Substance Use Disorders | Substance Dependence
Item
alcohol or drug abuse or dependence diagnosed in the last month prior to entry,
boolean
C0038586 (UMLS CUI [1])
C0038580 (UMLS CUI [2])
C0038580 (UMLS CUI [2])